ASTA Draft Risk Profile Comments
ASTA issued a comment to the Food and Drug Administration (FDA) in March 2014 regarding the FDA's Draft Risk Profile on Pathogens and Filth in Spice.
03/03/2014 at 5:15 am
1
Related Resources
ASTA Comments on FDA's Allergen Draft Guidance
ASTA submitted comments to the Food and Drug Administration(FDA) in August 2022 in response and support of the FDA's Draft Guidance for FDA Staff and Stakeholders: Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Ac. ASTA comments note that this Draft Guidance provides a science-based framework for protecting public health with respect to allergen issues.
ASTA Comments to FDA on Allergen Thresholds
ASTA issued comments to the Food and Drug Administration (FDA) in May 2013 regarding allergen thresholds, advocating for FDA's role to protect public health and the food supply by adopting allergen policies based on sound science and thoughtful policy.